WOCKHARDT
|
WOCKHARDT Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -30.06 | -38.82 | -16.94 | 62.36 | -6.25 |
| CEPS(Rs) | -16.17 | -25.69 | -2.22 | -4.27 | 7.17 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 217.27 | 231.81 | 266.04 | 304.36 | 238.55 |
| Tax Rate(%) | -12.38 | 0.48 | 32.12 | 47.71 | 59.67 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 1.08 | 2.36 | 5.81 | -1.36 | 3.44 |
| EBIT Margin(%) | -3.19 | -7.54 | -2.18 | -6.88 | -2.33 |
| Pre Tax Margin(%) | -11.65 | -14.60 | -8.01 | -12.25 | -12.03 |
| PAT Margin (%) | -13.09 | -14.53 | -5.44 | -6.41 | -4.85 |
| Cash Profit Margin (%) | -6.91 | -8.66 | -0.62 | -1.10 | 3.03 |
| Performance Ratios | |||||
| ROA(%) | -6.67 | -8.42 | -3.71 | -3.93 | -1.80 |
| ROE(%) | -14.12 | -17.32 | -7.77 | -9.92 | -5.22 |
| ROCE(%) | -2.15 | -5.88 | -1.96 | -5.50 | -1.11 |
| Asset Turnover(x) | 0.51 | 0.58 | 0.68 | 0.61 | 0.37 |
| Sales/Fixed Asset(x) | 0.63 | 0.73 | 0.88 | 0.75 | 0.44 |
| Working Capital/Sales(x) | -5.02 | -2.81 | -6.73 | -5.52 | -2.59 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.58 | 1.37 | 1.14 | 1.33 | 2.25 |
| Receivable days | 71.63 | 73.25 | 65.29 | 85.04 | 161.49 |
| Inventory Days | 65.71 | 60.95 | 55.76 | 59.63 | 98.54 |
| Payable days | 255.81 | 293.71 | 232.91 | 255.87 | 263.19 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | 6.12 | - |
| PCE(x) | -36.09 | -5.99 | -118.71 | -89.37 | 22.20 |
| Price/Book(x) | 2.69 | 0.66 | 0.99 | 1.36 | 0.72 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 3.78 | 1.50 | 1.63 | 2.44 | 1.71 |
| EV/Core EBITDA(x) | 86.64 | 17.85 | 16.52 | 95.62 | 30.78 |
| EV/EBIT(x) | -91.91 | -12.36 | -46.92 | -20.68 | -73.27 |
| EV/CE(x) | 1.93 | 0.76 | 0.69 | 0.89 | 0.63 |
| M Cap / Sales | 3.21 | 0.84 | 1.18 | 1.68 | 0.67 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 5.55 | -17.93 | 19.28 | -4.78 | -20.24 |
| Core EBITDA Growth(%) | -45.29 | -29.87 | 360.87 | -56.28 | 1,004.01 |
| EBIT Growth(%) | 64.29 | -187.50 | 64.89 | -381.15 | 63.45 |
| PAT Growth(%) | 23.99 | -122.58 | 6.06 | -115.30 | 55.76 |
| EPS Growth(%) | 22.55 | -129.10 | -127.17 | 1,097.71 | 64.44 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.63 | 0.57 | 0.49 | 0.70 | 1.22 |
| Current Ratio(x) | 0.74 | 0.56 | 0.76 | 0.73 | 0.69 |
| Quick Ratio(x) | 0.51 | 0.37 | 0.52 | 0.47 | 0.48 |
| Interest Cover(x) | -0.38 | -1.07 | -0.37 | -1.28 | -0.24 |
| Total Debt/Mcap(x) | 0.24 | 0.85 | 0.49 | 0.51 | 1.68 |
Compare Financial Ratios of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹16,374.7 Cr | 0.3% | 6% | 396.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,336.0 Cr | -1.9% | -0.6% | 64.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹153,351.0 Cr | -2.5% | 7.1% | 63.9% | Stock Analytics | |
| CIPLA | ₹120,235.0 Cr | -2.2% | -9.4% | 26.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,706.0 Cr | -2.7% | -2.7% | 18.7% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹99,637.3 Cr | -1.5% | -6.9% | 76.2% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 0.3% |
6% |
396.2% |
| SENSEX | -2.2% |
-6.5% |
21.4% |
You may also like the below Video Courses
